Sitemap - March, 2006 - Medical Marketing and Media

Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Email*

Password*

Keep me logged in Forgot your password?

Email*

March, 2006:

Pfizer begins new Lipitor advertising today

CHC petitions FDA, seeking new DTC advertising rules

Ambien steps up marketing to downplay reports

Crestor sales get lift from study results

AIDS drug combo may also be effective in preventing spread of HIV

FTC to probe practice of authorized generics

AstraZeneca marketing practices subject of US probe

Novartis sales reps demand overtime pay in $225 million lawsuit

AMP honors sales prowess at 2006 Nexus Awards

Product news from the 03/31/06 News Brief

People news from the 03/31/06 News Brief

Company news from the 03/31/06 News Brief

Viagra plotting TV comeback

Bayer white-knight bid for Schering poised to create German drug giant

FDA panels weigh in on ADHD drugs

Merck enters collaboration deals to help boost pipeline

FDA decision on Tysabri pushed back

Bristol-Myers Squibb, Sanofi-Aventis settle with Apotex in Plavix patent case

Novartis study to compare Femara with AstraZeneca’s Arimidex

Forest sues Teva over Lexapro patent

Patient deaths, illnesses cloud clinical trials

Product News from the 03/24/06 News Brief

People news from the 03/24/06 News Brief

Company news from the 03/24/06 News Brief

Korean scientist accused of faking journal article data is fired

FDA to partner with industry, academia as it moves further down ‘Critical Path’

Bush nominates von Eschenbach as FDA commissioner

PhRMA taps BMS’s Dolan as trade group chairman

Rebranding, acquisitions at Ventiv

Study analysis finds Vytorin works better than Lipitor

AstraZeneca to pay Merck $3.3 billion as part of marketing deal

Ambien linked to sleep-eating

Healthy Grey eliminated as part of Grey Global restructure

Product news from the 03/17/06 News Brief

People News from the 03/17/06 News Brief

Company news from the 03/17/06 News Brief

Account wins from 03/17/06 News Brief

AstraZeneca seeking innovation from the outside: WSJ

Tysabri gets panel nod to return to market

Emerging trends in focus at eMarketing conference

FDA advisors considering Tysabri

Group urges Congress to help spur discovery of new antibiotics

Marketing management changes at Pfizer

AstraZeneca moves Crestor professional to Saatchi

AstraZeneca ends contract sales agreement with PDI

Interlink handling interactive on new BMS patch

GlaxoSmithKline temporarily blocks sale of generic Flonase

DDMAC sees ‘huge’ jump in number of ads submitted for review

J&J’s Scios to eliminate sales and marketing jobs

Date set for 1st Celebrex trial

Prescription drug sales up 5.4% in 2005: IMS Health

Product News from 03/03/06 News Brief

People News from 03/03/06 News Brief

Account wins from 03/03/06 News Brief

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma.